ADC

CNNMoney.com »

Market Tracker

01/30 6:05pm ET

Dow
-251.90
17,164.95
-1.45%
S&P 500
-26.26
1,994.99
-1.30%
Nasdaq
-48.17
4,635.24
-1.03%
Russell 2000
-24.79
1,165.39
-2.08%
FTSE 100
-61.20
6,749.40
-0.90%
DAX
-43.55
10,694.32
-0.41%

Merck & Co Inc (NYSE:MRK)

Add to Watch List

60.28

Data as of Jan 30

-1.81 / -2.92%

Today’s Change

51.92

Today|||52-Week Range

63.62

+6.15%

Year-to-Date

Latest MRK News | Press Releases

US profitability: the rich list Jan 30 / FT.com	Young Investors Are Buying the Wrong Stocks Jan 21 / MotleyFool.com
Roche confident of regaining lead in cancer drugs race Jan 28 / FT.com	Thanks, Obamacare! Health insurer stocks soar Jan 21 / CNNMoney.com
Fast Money Halftime Report Final Trade From January 27 Jan 27 / Benzinga	Sanofi and Boehringer Ingelheim Ink Strategic Deal - Analyst Blog Jan 20 / Zacks.com
White House Budget To Support Biotech Rally Jan 27 / Benzinga	Top Trade Ideas For The Week January 20, 2015: Bonus Idea Jan 18 / StockTwits
Broker Darlings Of The Dow: Merck Ranks As A Top 15 Analyst Pick Jan 27 / TheStreet.com	Could This Common Medicine Cabinet Supplement Be the Key to Increased Survival for So... Jan 18 / MotleyFool.com
Advaxis: Legit Reasons to Take Another Look at Under-Appreciated Cancer Immunotherapy Jan 27 / TheStreet.com	3 Big Pharma Stocks With More Free Cash Flow Than Gilead Sciences Inc. Jan 18 / MotleyFool.com
Pfizer's Prevenar 13 Wins CHMP Backing for Expanded Use - Analyst Blog Jan 26 / Zacks.com	J&J receives b,100m EU injection for Ebola vaccine development Jan 16 / FT.com
This Popular Beverage Could Be Responsible For a 20% Reduction in Melanoma Risk Jan 26 / MotleyFool.com	Healthcare: Counting the cost of cancer Jan 15 / FT.com
GSK ships Ebola vaccine to west Africa Jan 23 / FT.com	Two Ebola vaccines given go-ahead for trials in west Africa Jan 09 / FT.com
Celgene to Use Zymeworks' Azymetric Platform for New Drugs - Analyst Blog Jan 22 / Zacks.com	New Ebola vaccine trial starts Jan 06 / CNNMoney.com